Skip to main navigation
Skip to main content
About Us
Overview
Leadership
Board of directors
Scientific advisory board
Corporate Responsibility
Contact us
FORCE
TM
Platform
Overview
Scientific publications & presentations
Pipeline
Overview
Zeleciment rostudirsen (DYNE-251)
Zeleciment basivarsen (DYNE-101)
DYNE-302
Physicians
Patients
Commitment
Clinical trials
DMD stories
DM1 stories
FSHD stories
Resources
Investors & Media
Company overview
News, publications & events
Stock information
Corporate governance
Financials & filings
IR resources
Culture & Careers
Our culture & values
Hear from our Dynamos
Competitive benefits
Open positions
About Us
FORCE
TM
Platform
Pipeline
Physicians
Patients
Investors & Media
Culture & Careers
Overview
Leadership
Board of directors
Scientific advisory board
Corporate Responsibility
Contact us
about-us
Overview
Scientific publications & presentations
force™-platform
Overview
Zeleciment rostudirsen (DYNE-251)
Zeleciment basivarsen (DYNE-101)
DYNE-302
pipeline
physicians
Commitment
Clinical trials
DMD stories
DM1 stories
FSHD stories
Resources
patients
Company overview
News, publications & events
Stock information
Corporate governance
Financials & filings
IR resources
investors--media
Our culture & values
Hear from our Dynamos
Competitive benefits
Open positions
culture--careers
Stay in Touch
info@dyne-tx.com
781.786.8230
linkedin.com
twitter.com
facebook.com
youtube.com
more
potential
Brian Skorney
Robert W. Baird & Co.
Print
Contact IR
RSS
Email Alerts
You are now leaving
the Dyne Therapeutics corporate website
Continue
Stay on page
